1. Hussein, Neveen A, El Sewedy, Shehata M, Zakareya, Mohamed M, Youssef, Engy A, Ibrahim, Fawziya A R. 2023. Expression status of circ-SMARCA5, circ-NOL10, circ-LDLRAD3, and circ-RHOT1 in patients with colorectal cancer. In Scientific reports, 13, 13308. doi:10.1038/s41598-023-40358-4. https://pubmed.ncbi.nlm.nih.gov/37587156/
2. Caba, Octavio, Irigoyen, Antonio, Jimenez-Luna, Cristina, Aranda, Enrique, Prados, Jose. 2016. Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinoma patients. In Toxicology and applied pharmacology, 311, 113-116. doi:10.1016/j.taap.2016.10.003. https://pubmed.ncbi.nlm.nih.gov/27720938/
3. Wei, Gong-Hong, Dong, Dandan, Zhang, Peng, Zhu, Jing, Wang, Liang. 2024. Combined SNPs sequencing and allele specific proteomics capture reveal functional causality underpinning the 2p25 prostate cancer susceptibility locus. In Research square, , . doi:10.21203/rs.3.rs-3943095/v1. https://pubmed.ncbi.nlm.nih.gov/38645058/
4. Hu, Xiaoyi, Bao, Mingyang, Huang, Jiacheng, Zhou, Lin, Zheng, Shusen. 2020. Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma. In Frontiers in oncology, 10, 541479. doi:10.3389/fonc.2020.541479. https://pubmed.ncbi.nlm.nih.gov/33102213/
5. Pereira, Guilherme L, Malheiros, Jessica M, Ospina, Alejandra M T, Chardulo, Luis Artur L, Curi, Rogério A. 2019. Exome sequencing in genomic regions related to racing performance of Quarter Horses. In Journal of applied genetics, 60, 79-86. doi:10.1007/s13353-019-00483-1. https://pubmed.ncbi.nlm.nih.gov/30666567/
6. Wang, J, Han, K, Li, Y, Luo, T, Bian, C-J. . Exploration and validation of the prognostic value of RNA-binding proteins in hepatocellular carcinoma. In European review for medical and pharmacological sciences, 26, 8945-8958. doi:10.26355/eurrev_202212_30569. https://pubmed.ncbi.nlm.nih.gov/36524514/